Skip to main content

Main menu

  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us

Clinical Medicine Journal

  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

User menu

  • Log in

Search

  • Advanced search
RCP Journals
Home
  • Log in
  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us
Advanced

Clinical Medicine Journal

clinmedicine Logo
  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

COVID-19 multidisciplinary working group

Atul Gulati, Jonathan Odum, Brian Mckaig, Helen Ward, James Cotton and Matthew J Brookes
Download PDF
DOI: https://doi.org/10.7861/clinmed.Let.21.4.7
Clin Med July 2021
Atul Gulati
Royal Wolverhampton NHS Trust, Wolverhampton, UK
Roles: Consultant in respiratory medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan Odum
Royal Wolverhampton NHS Trust, Wolverhampton, UK
Roles: Consultant renal physician and chief medical officer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian Mckaig
Royal Wolverhampton NHS Trust, Wolverhampton, UK
Roles: Consultant gastroenterologist and acting chief medical officer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Helen Ward
Royal Wolverhampton NHS Trust, Wolverhampton, UK
Roles: Consultant in respiratory medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James Cotton
Royal Wolverhampton NHS Trust, Wolverhampton, UK
Roles: Consultant cardiologist
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew J Brookes
Royal Wolverhampton NHS Trust, Wolverhampton, UK
Roles: Consultant gastroenterologist
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Editor – We write in support of the process outlined by Satta et al in their recent commentary which explored the methods for creating an expert multidisciplinary team (MDT) to support decision making and governance around therapeutic options during the COVID-19 pandemic.1

Within our own organisation, a large district general hospital, we established a similar COVID-19 oversight group (COG) by mid-April 2020, drawing in multiple experts, like those reported by Satta et al. We developed the trust-wide guidelines for managing COVID-19 and maximised the delivery of clinical trials, overseeing study outcomes with early implementation of efficacious treatments through this group.

During the COVID-19 pandemic, up to 10 May 2021, our organisation recruited 5,431 participants into research studies of which 6% (n=333) were recruited to interventional trials including RECOVERY (n=222) and REMAP-CAP (n=15).2,3

The COG was also able to review, through weekly virtual meetings, the outcomes from various research studies and interim position statements released from the department of health. Various novel therapeutic agents were implemented into updated guidelines within 7 days of release of the interim position statements with effective transition into standard care within this time period.2–4

In order to evaluate the impact of the COG guidelines, we undertook a trust-wide audit of randomly selected COVID-19 patients admitted between 01 May 2020 and 30 Nov 2020. The majority of patients received appropriate therapeutic interventions during the audit time periods: dexamethasone (93%) and remdesivir (84%). Tocilizumab guidance was received in January 2021 and a further audit suggested that 86% of our patients received this treatment appropriately.

We agree with the authors and feel confident that the establishment of a local MDT has enabled our organisation to provide rapid access to therapeutic interventions in COVID-19 with high levels of concordance with local guidelines. Although NHS organisations have a wide degree of heterogeneity, we believe that the effective implementation of a local COVID-19 MDT group could have beneficial impact across the wider healthcare system.

  • © Royal College of Physicians 2021. All rights reserved.

References

  1. ↵
    1. Satta G
    , Youngstein T, Lightstone L, et al. The utility of a local multidisciplinary working group to oversee the establishment of rapidly evolving standards of care and to support trial recruitment during the COVID-19 pandemic. Clin Med 2021;21:e287–9.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. RECOVERY Collaborative Group
    . Dexamethasone in hospitalized patients with Covid-19. N Engl J Med 2021;384:693–704.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Beigel JH
    , Tomashek KM, Dodd LE, et al. Remdesivir for the treatment of Covid-19. N Engl J Med 2020;383:1813–26.
    OpenUrlCrossRefPubMed
  4. ↵
    1. REMAP-CAP Investigators
    . Interleukin-6 receptor antagonists in critically ill patients with Covid-19. N Engl J Med 2021;384:1491–502.
    OpenUrlPubMed
Back to top
Previous articleNext article

Article Tools

Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
COVID-19 multidisciplinary working group
Atul Gulati, Jonathan Odum, Brian Mckaig, Helen Ward, James Cotton, Matthew J Brookes
Clinical Medicine Jul 2021, 21 (4) e429-e430; DOI: 10.7861/clinmed.Let.21.4.7

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
COVID-19 multidisciplinary working group
Atul Gulati, Jonathan Odum, Brian Mckaig, Helen Ward, James Cotton, Matthew J Brookes
Clinical Medicine Jul 2021, 21 (4) e429-e430; DOI: 10.7861/clinmed.Let.21.4.7
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • References
  • Info & Metrics

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • The association of pleural effusion and pulmonary embolism
  • What is the impact of COVID-19 on complaints against doctors?
  • The significance of the gut microbiome in post-COVID-19 gastrointestinal symptoms
Show more Letters to the editor

Similar Articles

FAQs

  • Difficulty logging in.

There is currently no login required to access the journals. Please go to the home page and simply click on the edition that you wish to read. If you are still unable to access the content you require, please let us know through the 'Contact us' page.

  • Can't find the CME questionnaire.

The read-only self-assessment questionnaire (SAQ) can be found after the CME section in each edition of Clinical Medicine. RCP members and fellows (using their login details for the main RCP website) are able to access the full SAQ with answers and are awarded 2 CPD points upon successful (8/10) completion from:  https://cme.rcplondon.ac.uk

Navigate this Journal

  • Journal Home
  • Current Issue
  • Ahead of Print
  • Archive

Related Links

  • ClinMed - Home
  • FHJ - Home
clinmedicine Footer Logo
  • Home
  • Journals
  • Contact us
  • Advertise
HighWire Press, Inc.

Follow Us:

  • Follow HighWire Origins on Twitter
  • Visit HighWire Origins on Facebook

Copyright © 2021 by the Royal College of Physicians